|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00108 SR MEDICAL
Nominal 
1.665 -0.015 (-0.893%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 223,138 | 30.702% | 327,914 | 310,017 | 352,640 | 352,276 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | (55,682) | (930,732) | (122,711) | (344,777) | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (69,067) | -- | (135,701) | (967,508) | (69,947) | (334,277) | |
| Taxation | 452 | -- | 25,677 | 48,164 | (59,360) | 14,151 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,986) | -- | 390 | 843 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (70,601) | -- | (109,634) | (918,501) | (129,307) | (320,126) | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | 89,742 | 54.483% | 147,364 | 111,453 | 121,485 | 131,708 |
| Depreciation & Amortisation | 5,934 | 1079.722% | 1,462 | 2,279 | 2,539 | 3,207 |
| Directors' Emoluments | -- | -- | 1,643 | 1,394 | 1,394 | 1,378 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified | Unqualified (Modified Report) | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -2.180 | -- | -3.410 | -28.710 | -4.040 | -10.010 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.038 | 0.025 | 0.038 | (0.033) |
| NBV per share ($) | 0.306 | -- | 0.291 | 0.300 | 0.603 | 0.649 |
| Remarks: | Real time quote last updated: 01/09/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -70,601 |
| %Change | -- |
| EPS / (LPS) | HKD -0.022 |
| NBV Per Share ($) | HKD 0.306 |